Company Overview - Aclarion, Inc. is a healthcare technology company focused on leveraging Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to enhance clinical treatments [2] - The company is primarily targeting the chronic low back pain market with its product Nociscan, which is the first evidence-supported SaaS platform designed to noninvasively help physicians differentiate between painful and non-painful discs in the lumbar spine [2] Product Details - Nociscan operates by receiving MRS data from MRI machines for each lumbar disc being evaluated, utilizing cloud-based proprietary signal processing techniques to extract and quantify chemical biomarkers associated with disc pain [2] - The platform integrates biomarker data into proprietary algorithms to indicate potential sources of pain, providing critical insights that assist physicians in optimizing treatment strategies [2] Upcoming Events - Aclarion's CEO, Brent Ness, is scheduled to present at the 2024 Maxim Healthcare Virtual Summit on October 15, 2024, at 2:00 PM ET, where he will engage in discussions with senior analysts and other healthcare technology companies [1]
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit